April 24, 2012
On March 26, 2012, Bracco released a customer letter with an update on the progress and path going forward since receiving the clearance from the Food and Drug Administration (FDA) to reintroduce CardioGen-82 (Rubidium Rb 82 Generator).
Because education and quality assessment are important to the process of reintroduction, Bracco has created and made commercially available generators for customers using the planning initiatives. Please click hereto review the initiatives.
Bracco is doing their best to project better generator shipment schedules on a regular basis and are making every effort to provide customers with a generator schedule timeline through June.
The SNM will keep you updated as information becomes available. To review the customer letter, please click here.